Doctor profile · Federal record

Dr. Sumeet Chandra, M.D.

Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Melbourne, FL

  • NPI 1801853171
  • Accepts Medicare
  • MIPS 95.1 / 100 · 2023
  • 27 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2290 W Eau Gallie Blvd, Ste 202
Melbourne, FL 329353145
(321) 254-4776
fax (321) 254-4840

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
May 4, 2023
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
Florida #ME101674 · Florida #ME 101674

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801853171. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
259,288
Distinct HCPCS
10
Medicare allowed
$3,128,481
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 90,750 60 $1
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 57,120 19 $0
J9271 Injection, pembrolizumab, 1 mg 34,200 22 $54
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 19,000 19 $3
J0897 Injection, denosumab, 1 mg 18,060 73 $23
J1453 Injection, fosaprepitant, 1 mg 14,850 20 $0
J1437 Injection, ferric derisomaltose, 10 mg 3,900 38 $21
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 3,560 21 $7
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,974 44 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 2,440 18 $8

In context: peer comparison

Among 4 peers in Melbourne Medical Oncology Physician, average services per provider: 3,077. This provider delivers 84× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,020
Transactions
62
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Pfizer INC. 11 $246.45
Merck Sharp & Dohme LLC 7 $156.49
Janssen Biotech, INC. 4 $116.83
Novartis Pharmaceuticals Corporation 6 $115.18
GlaxoSmithKline, LLC. 5 $105.23
Regeneron Healthcare Solutions, INC. 3 $75.36
E.R. Squibb & Sons, L.L.C. 4 $73.69
Eisai INC. 3 $71.11
Takeda Pharmaceuticals U.S.A., INC. 3 $70.96
Sobi, INC 2 $70.12
Taiho Oncology, INC. 3 $70.12
Bayer Healthcare Pharmaceuticals INC. 3 $69.82
Incyte Corporation 3 $66.35
Astellas Pharma US INC 3 $64.77
AstraZeneca Pharmaceuticals Lp 2 $57.69

By nature of payment

Food and Beverage
$2,009
Education
$11

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
400
Patients
56
Total drug cost
$1,662,825
Drug Type Claims Patients Total cost
Anastrozole Generic 76 29 $2,327
Revlimid (Lenalidomide) Brand 61 0 $1,043,314
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 36 16 $2,227
Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50) Brand 34 0 $137,396
Hydroxyurea Generic 32 11 $1,064
Lenalidomide Generic 27 0 $282,481
Xarelto (Rivaroxaban) Brand 22 0 $14,152
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 21 0 $1,168
Tamoxifen Citrate Generic 20 0 $728
Oxycodone Hcl Generic 19 0 $673

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Sumeet Chandra's medical specialty?
Dr. Sumeet Chandra practices Medical Oncology Physician in Melbourne, FL.
Where does Dr. Sumeet Chandra practice?
Dr. Sumeet Chandra practices at 2290 W Eau Gallie Blvd, Melbourne, FL 329353145. Office phone: 3212544776.
What is Dr. Sumeet Chandra's NPI?
Dr. Sumeet Chandra's National Provider Identifier (NPI) is 1801853171, issued by NPPES.
Does Dr. Sumeet Chandra accept Medicare assignment?
Yes. Dr. Sumeet Chandra accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sumeet Chandra commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.